Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-26 Purchase |
2021-05-27 5:18 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
12,500 | $3.5966 | $44,958 | 37,500 (Direct) |
View |
| 2021-05-06 Sale |
2021-05-07 5:31 pm |
VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,000,000 | $3.67 | $3,670,000 | 5,773,954 (Indirect) |
View |
| 2021-03-15 Purchase |
2021-03-16 4:38 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
12,500 | $7.405 | $92,563 | 25,000 (Direct) |
View |
| 2021-01-28 Purchase |
2021-02-01 5:31 pm |
VYNE Therapeutics Inc. | VYNE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
4,219,409 | $2.37 | $9,999,999 | 27,095,819 (Indirect) |
View |
| 2020-12-03 Purchase |
2020-12-07 4:31 pm |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
50,000 | $1.7085 | $85,425 | 50,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-19 Option Award |
2021-07-20 5:06 pm |
N/A 2031-07-19 |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 5:05 pm |
N/A 2031-07-19 |
VYNE Therapeutics Inc. | VYNE | Bruno Anthony D Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 5:05 pm |
N/A 2031-07-19 |
VYNE Therapeutics Inc. | VYNE | Bright Rex Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 5:04 pm |
N/A 2031-07-19 |
VYNE Therapeutics Inc. | VYNE | Basta Steven L Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 5:04 pm |
N/A 2031-07-19 |
VYNE Therapeutics Inc. | VYNE | BARBARI SHARON Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:37 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO |
700 | $3.51 | 22,695 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:36 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
5,151 | $3.51 | 109,246 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:36 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
3,083 | $3.51 | 95,750 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:36 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
3,551 | $3.51 | 105,322 (Direct) |
View |
| 2021-06-30 Tax Withholding |
2021-07-02 4:35 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
18,859 | $3.51 | 455,599 (Direct) |
View |
Ownership |
2021-06-21 5:19 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Zeronda Tyler Interim CFO |
0 | $0 | 69,483 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
3,017 | $3.3575 | 116,468 (Direct) |
View |
| 2021-05-28 Option Award |
2021-06-02 4:30 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
941 | $3.3575 | 474,458 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 12:15 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
2,573 | $6.84 | 114,397 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 12:14 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
1,945 | $6.84 | 98,833 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 12:14 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
762 | $6.84 | 113,451 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 12:14 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,765 | $6.84 | 108,873 (Direct) |
View |
| 2021-03-31 Tax Withholding |
2021-04-02 12:13 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
6,316 | $6.84 | 473,517 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 4:40 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
92,250 | $0 | 181,545 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 4:39 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
97,375 | $0 | 168,940 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 4:39 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer |
97,375 | $0 | 182,375 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 4:38 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
97,375 | $0 | 178,800 (Direct) |
View |
| 2021-02-22 Option Award |
2021-02-24 4:37 pm |
N/A 2031-02-22 |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
512,500 | $0 | 838,583 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
1,541 | $1.58 | 357,181 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
2,378 | $1.58 | 286,262 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,822 | $1.58 | 325,703 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
9,656 | $1.58 | 1,304,334 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
7,838 | $1.445 | 358,722 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
10,460 | $1.445 | 327,525 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:30 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
4,263 | $1.445 | 1,313,990 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-02 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Wiley Matthew T. Chief Commercial Officer |
1,541 | $1.66 | 350,884 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-02 4:32 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Stuart Iain Chief Scientific Officer |
2,378 | $1.66 | 288,640 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Harsch Mutya Chief Legal Officer and GC |
1,822 | $1.66 | 317,065 (Direct) |
View |
| 2020-09-30 Tax Withholding |
2020-10-02 4:31 pm |
N/A N/A |
VYNE Therapeutics Inc. | VYNE | Domzalski David President and CEO |
6,239 | $1.66 | 1,309,727 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 4:39 pm |
N/A 2030-09-10 |
VYNE Therapeutics Inc. | VYNE | LEPORE PATRICK G Director |
45,000 | $0 | 45,000 (Direct) |
View |